Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Ban

Showing results (171-180 of 362) with videos related to

Pageof 37
Sort By:
Current Therapeutic Research, Clinical and Experimental|January 1, 1971
Doxepin as adjuvant medication in the treatment of chronic schizophrenic patients: a comparative studyC Sterlin, E Augustin, T A Ban, et al.
Canadian Medical Association Journal|February 20, 1971
Urinary incontinence associated with thioridazine administrationJ V Ananth, T A Ban, H E Lehmann
Canadian Psychiatric Association Journal|August 1, 1972
Nicotinic acid, thioridazine, fluoxymesterone and their combinations in hospitalized geriatric patients: a systematic clinical studyH E Lehmann, T A Ban, B M Saxena
Psychopharmacology Bulletin|January 1, 1976
Proceedings: Introduction to the symposium on systematic studies with psychoactive drugs--new methods in the assessment of changeJ C Pecknold, T A Ban, H E Lehmann
Psychopharmacology Bulletin|July 1, 1977
A standard-controlled clinical study with benzquinamide in the treatment of chronic schizophrenic patientsM M Amin, T A Ban, H E Lehmann
International Pharmacopsychiatry|January 1, 1981
The use of nicotinic acid and pyridoxine in the treatment of schizophreniaW M Petrie, T A Ban, J V Ananth
International Pharmacopsychiatry|January 1, 1975
Psychotherapeutic profile of a new psychoactive drug trazodone (AF-1161)H E Lehmann, T A Ban, G V Schwartz
Canadian Medical Association Journal|March 28, 1970
Toxic psychotic syndrome associated with chlorpromazine administrationJ V Anath, T A Ban, H E Lehmann
Psychopharmacology Bulletin|July 1, 1977
Introduction to the colloquium on new drugs in the treatment of schizophreniaM M Amin, T A Ban, H E Lehmann
Activitas Nervosa Superior|March 1, 1974
Conditioning in the prediction of drug withdrawal effects in chronic schizophrenic patientsT A Ban, J V Ananth, H E Lehmann
Pageof 37

Showing results (171-180 of 362) with videos related to

Sort By:
Pageof 37
Current Therapeutic Research, Clinical and Experimental|January 1, 1971
Doxepin as adjuvant medication in the treatment of chronic schizophrenic patients: a comparative studyC Sterlin, E Augustin, T A Ban, et al.
Canadian Medical Association Journal|February 20, 1971
Urinary incontinence associated with thioridazine administrationJ V Ananth, T A Ban, H E Lehmann
Canadian Psychiatric Association Journal|August 1, 1972
Nicotinic acid, thioridazine, fluoxymesterone and their combinations in hospitalized geriatric patients: a systematic clinical studyH E Lehmann, T A Ban, B M Saxena
Psychopharmacology Bulletin|January 1, 1976
Proceedings: Introduction to the symposium on systematic studies with psychoactive drugs--new methods in the assessment of changeJ C Pecknold, T A Ban, H E Lehmann
Psychopharmacology Bulletin|July 1, 1977
A standard-controlled clinical study with benzquinamide in the treatment of chronic schizophrenic patientsM M Amin, T A Ban, H E Lehmann
International Pharmacopsychiatry|January 1, 1981
The use of nicotinic acid and pyridoxine in the treatment of schizophreniaW M Petrie, T A Ban, J V Ananth
International Pharmacopsychiatry|January 1, 1975
Psychotherapeutic profile of a new psychoactive drug trazodone (AF-1161)H E Lehmann, T A Ban, G V Schwartz
Canadian Medical Association Journal|March 28, 1970
Toxic psychotic syndrome associated with chlorpromazine administrationJ V Anath, T A Ban, H E Lehmann
Psychopharmacology Bulletin|July 1, 1977
Introduction to the colloquium on new drugs in the treatment of schizophreniaM M Amin, T A Ban, H E Lehmann
Activitas Nervosa Superior|March 1, 1974
Conditioning in the prediction of drug withdrawal effects in chronic schizophrenic patientsT A Ban, J V Ananth, H E Lehmann
Pageof 37